Nonalcoholic Fatty Liver Disease: A Clinical Review
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“Brunt’s classification (reported in Table 2) is a system that unifies the steatotic and necroinflammatory lesions into a “grade” and the types of fibrosis into a “stage” (50).”
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“The importance of relating the natural history of NAFLD to the different histologic forms has been reported in a retrospective study (56).”
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473 · cited 13×
“Three studies, one with a follow-up exceeding 20 years (27), corroborate these viewpoints.”
InfluentialThe prevalence and etiology of elevated aminotransferase levels in the United States
Clark, J. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00265-x · Cited by 1,360
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305 · cited 1×
“Bacterial toxins (20), overproduction of cytokines (especially tumor necrosis factor-α) (21), and alteration of hepatocyte ATP stores and cytochrome P450 Cyp2E1/Cyp4A enzyme activity (22) are also putative triggers for disease progression and fibrogenesis.”
LLUSIA, J. B. (1983) · PubMed · Cited by 1,289
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Non‐alcoholic fatty liver disease
ANGULO, P., & LINDOR, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 835
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 810
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727 · cited 1×
“Despite four open-label, small-scale pilot studies suggesting benefits of UDCA in NASH, this was not borne out in the only randomized, placebo-controlled trial, where UDCA at 13– 15 mg/kg/day for 2 years, although safe and well tolerated, was not associated with an improvement in liver biochemistry or histology as com…”
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726 · cited 2×
“A small pilot study with pioglitazone for 1 year in 18 NASH patients without diabetes also resulted in significant improvements in insulin sensitivity, serum ALT, and histologic features (70).”
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Marrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 659
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 609
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550
Textbook of Gastrointestinal Radiology
Gore, E. B. R. M., & Levine, M. S. (2007) · Medical Entomology and Zoology · Cited by 537
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 531
Sheth, S. G., Gordon, F. D., & Chopra, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00008 · Cited by 513
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 501
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489
Alcohollike liver disease in nonalcoholics
Diehl, A. M., Goodman, Z., & Ishak, K. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90183-7 · Cited by 483
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Abdelmalek, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02691-0 · Cited by 439
Tominaga, K., Kurata, J. H., Chen, Y. K., Fujimoto, E., Miyagawa, S., Abe, I., & Kusano, Y. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02208670 · Cited by 406
Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, S. A., Fisher, R. A., Ham, J., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell, S. H., Hespenheide, E. E., Redick, J. A., Iezzoni, J. C., Battle, E. H., & Sheppard, B. L. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03553.x · Cited by 394 · cited 1×
“An insulin-sensitizing medication, troglitazone (a thiazolidinedione), administered for 3–6 months in a small, nonrandomized series showed normalization of ALT in 7 of 10 subjects, and although necroinflammation was still noted on follow-up liver biopsy in all 7, the grade of inflammation had improved in 4 subjects (6…”
Reid, A. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.27126 · Cited by 394
Mitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 391
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
Longo, R., Pollesello, P., Ricci, C., Masutti, F., Kvam, B. J., Bercich, L., Croce, L. S., Grigolato, P., Paoletti, S., De Bernard, B., et al. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050311 · Cited by 387
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Saviano, M. C., Brunetti, F., Rubino, A., Franzese, A., Vajro, P., Argenziano, A., Puzziello, A., & Iannucci, M. P. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018850223495 · Cited by 365
Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 362
Prevalence of fatty liver in a general population of Okinawa, Japan.
NOMURA, H., KASHIWAGI, S., HAYASHI, J., KAJIYAMA, W., TANI, S., & GOTO, M. (1988) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.27.142 · Cited by 355
Daniel, S. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00507-9 · Cited by 354
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
Basaranoglu, M., Acbay, O., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 305
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
Charlton, M., Kasparova, P., Weston, S., Lindor, K., Maor-Kendler, Y., Wiesner, R. H., Rosen, C. B., & Batts, K. P. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25453 · Cited by 261
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
Ong, J., Younossi, Z. M., Reddy, V., Price, L. L., Gramlich, T., Mayes, J., & Boparai, N. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.24644 · Cited by 258
Serum leptin levels in patients with nonalcoholic steatohepatitis
Uygun, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02090-6 · Cited by 256
Turner, J. G., Brownlie, B. E. W., & Sadler, W. A. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91339-2 · Cited by 253
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Hepatic iron and nonalcoholic fatty liver disease
Younossi, Z. M., Gramlich, T., Bacon, B. R., Matteoni, C. A., Boparai, N., O'Neill, R., & McCullough, A. J. (1999) · Hepatology · doi:10.1002/hep.510300407 · Cited by 238
Drenick, E. J., Fisler, J., & Johnson, D. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80403-4 · Cited by 226
Ultrasonographical Diagnosis of Fatty Liver: Significance of the Liver-Kidney Contrast
YAJIMA, Y., OHTA, K., NARUI, T., ABE, R., SUZUKI, H., & OHTSUKI, M. (1983) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.139.43 · Cited by 189
Nonalcoholic fatty liver disease: What nurses need to know
(2020) · Nursing · doi:10.1097/01.nurse.0000656496.00204.01 · Cited by 179
Mendler, M.-H., Bouillet, P., Sidaner, A. L., Lavoine, E., Labrousse, F., Sautereau, D., & Pillegand, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80228-6 · Cited by 153
Weinsier, R. L., Wilson, L. J., & Lee, J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80394-5 · Cited by 148
Rubbia-Brandt, L., Leandro, G., Spahr, L., Giostra, E., Quadri, R. A., Malé, P. J., & Negro, F. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01208.x · Cited by 129
Hézode, C., Lonjon, I., Roudot‐Thoraval, F., Pawlotsky, J., Zafrani, É. S., & Dhumeaux, D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01546.x · Cited by 128
Hepatotoxicity of the thiazolidinediones
Tolman, K. G., & Chandramouli, J. C. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00020-5 · Cited by 124
Intestinal Bypass Surgery for Morbid Obesity: Long-Term Results
DeWind, L. T., & Payne, J. H. (2014) · JAMA · doi:10.1001/jama.2014.10853 · Cited by 118
Intestinal Bypass Surgery for Morbid Obesity: Long-Term Results
DeWind, L. T. (1976) · JAMA · doi:10.1001/jama.1976.03270210024017 · Cited by 115
Computed tomography attenuation values in fatty liver
Bydder, G. M., Chapman, R. W., Harry, D. S., Bassan, L., Sherlock, S., & Kreel, L. (1981) · Journal of Computed Tomography · doi:10.1016/0149-936x(81)90054-0 · Cited by 112
Nalpas, B., Vassault, A. J., Charpin, S., Lacour, B., & Berthelot, P. (1986) · Hepatology · doi:10.1002/hep.1840060410 · Cited by 107
Efficacy and Safety of Oral Betaine Glucuronate in Non-alcoholic Steatohepatitis
Miglio, F., Rovati, L., Santoro, A., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300279 · Cited by 106
Non‐alcoholic fatty liver disease
Alba, L. M., & Lindor, K. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01493.x · Cited by 105
DESIALYLATED TRANSFERRIN AS A SEROLOGICAL MARKER OF CHRONIC EXCESSIVE ALCOHOL INGESTION
Storey, E., Mack, U., Anderson, G. J., Powell, L. W., & Halliday, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90544-7 · Cited by 101
Balkestein, E. J., van Aggel-Leijssen, D. P., van Baak, M. A., Struijker-Boudier, H. A., & Van Bortel, L. M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917121-00008 · Cited by 89
Use of Enzymes for the Diagnosis of Alcohol-Related Organ Damage
Salaspuro, M. P. (2017) · Enzyme · doi:10.1159/000469243 · Cited by 85
Fletcher, L. M., Kwoh-Gain, I., Powell, E. E., Powell, L. W., & Halliday, J. W. (1991) · Hepatology · doi:10.1002/hep.1840130312 · Cited by 76
Nonalcoholic Steatohepatitis: Reply
Sheth, S. G., Gordon, F. D., & Chopra, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-5-199709010-00019 · Cited by 57
Näslund, I. (1987) · PubMed · Cited by 57
Sonsuz, A., Başaranoğlu, M., & Özbay, G. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00838-8 · Cited by 54
ABC of alcohol: tools of detection.
Lewis, K. O., & Paton, A. (1981) · BMJ · doi:10.1136/bmj.283.6305.1531 · Cited by 35
Adams, L. A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08695.x · Cited by 31
Nonalcoholic Steatohepatitis Masquerading as Autoimmune Hepatitis
Tajiri, K., Takenawa, H., Yamaoka, K., Yamane, M., Marumo, F., & Sato, C. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199710000-00012 · Cited by 29
Kleiner, D. E., Brunt, E. M., VANNATTA, M., Behling, C. A., Contos, M. J., Cummings, O. W., Ferrell, L. D., LIU, Y., Torbenson, M. S., & Yeh, M. (2003) · Hepatology · doi:10.1016/s0270-9139(03)80203-3 · Cited by 19
Cited by
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Zivkovic, A. M., German, J. B., & Sanyal, A. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.285 · Cited by 422
Non-alcoholic fatty liver disease: The diagnosis and management
El-Kader, S. M. A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i6.846 · Cited by 381
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 318
Metadata
- Authors
- Sass, D. A., Chang, P., & Chopra, K. B.
- Venue
- Digestive Diseases and Sciences
- Published
- 2005-01
- Volume
- 50
- Issue
- 1
- Pages
- 171-180
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2098223416
- Cited by
- 267
- References
- 83
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.